Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CNS-selective effects of synthetic, nonfeminizing estrogens

July 7, 1998

New antimigraine option now available in Canada

July 7, 1998

Ganaxolone study results presented at AASH meeting

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease

July 7, 1998

S-8510 enhances cognition and acetylcholine release in basal forebrain-lesioned rats

July 6, 1998

CNI-1493 treatment associated with improvement in mouse model of MS

July 6, 1998

Nihon Nohyaku claims arylpiperidines for schizophrenia, dementia

July 6, 1998

Berlex and Chiron file with FDA to treat progressive form of MS

July 6, 1998

Analgesics prepared at Ostuka

July 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...